Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 5, 2020
Reporting Period: Event-based disclosure regarding a scheduled investor presentation.
Key Financial Metrics
This filing is a regulatory disclosure regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or operational updates were reported in this document. The filing solely announces a scheduled management presentation.
Guidance, Outlook, and Management Commentary
- Event Announcement: Management will present at the 32nd Annual Roth Conference.
- Date and Time: Tuesday, March 17, 2020, at 8:30 a.m. (PT).
- Format: The presentation will include one-on-one meetings with management.
- Regulatory Note: The accompanying press release (Exhibit 99.1) is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the content of the press release (Exhibit 99.1) for specific details on the presentation agenda.
- Confirm the company's status as an emerging growth company (indicated as yes in the filing).
- Review subsequent filings for the actual results or commentary delivered at the March 17, 2020 conference.